Silence Therapeutics (SLN) Non-Current Assets: 2019-2025
Historic Non-Current Assets for Silence Therapeutics (SLN) over the last 7 years, with Sep 2025 value amounting to $13.2 million.
- Silence Therapeutics' Non-Current Assets fell 14.69% to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.6 million, marking a year-over-year decrease of 2.88%. This contributed to the annual value of $15.3 million for FY2024, which is 6.31% down from last year.
- Latest data reveals that Silence Therapeutics reported Non-Current Assets of $13.2 million as of Q3 2025, which was down 21.12% from $16.7 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Non-Current Assets ranged from a high of $16.7 million in Q2 2025 and a low of $12.5 million during Q3 2022.
- Over the past 3 years, Silence Therapeutics' median Non-Current Assets value was $15.4 million (recorded in 2024), while the average stood at $14.8 million.
- Per our database at Business Quant, Silence Therapeutics' Non-Current Assets increased by 28.49% in 2023 and then dropped by 14.69% in 2025.
- Silence Therapeutics' Non-Current Assets (MRQ) stood at $13.3 million in 2021, then decreased by 4.58% to $12.7 million in 2022, then rose by 28.49% to $16.3 million in 2023, then decreased by 6.31% to $15.3 million in 2024, then fell by 13.83% to $13.2 million in 2025.
- Its Non-Current Assets stands at $13.2 million for Q3 2025, versus $16.7 million for Q2 2025 and $15.5 million for Q1 2025.